Pluripotent stem cell (PSC) research is an expanding field that has the potential to change the way human diseases are studied and treated. See More The ability to differentiate embryonic stem (ES) cells and induced pluripotent stem (iPS) cells to specific downstream cell types opens up new avenues for drug development and regenerative medicine. From generation of iPS cells to maintenance, differentiation, characterization, and cryopreservation of ES and iPS cells, see how you can "Maximize Your Pluripotential" with the most complete, defined system for ES and iPS cell culture. For help with your hPSC workflow decision making, use our infographics to find the right reagents for you.
Read this mini-review to learn more about Pluripotent Stem Cells.See Less
Explore These Resources
Deficiency of MicroRNA miR-34a Expands Cell Fate Potential in Pluripotent Stem Cells
Researchers showed that microRNA miR-34a deficiency expands the developmental potential of mouse pluripotent stem cells to yield both embryonic and extra-embryonic lineages and strongly induce MuERV-L endogenous retroviruses, similar to what is seen with totipotent 2-cell blastomeres.ESC & iPSC News Volume 12.02, January 18, 2017. Read full issue at